Oncology Division
Alphabetical list (active faculty):   
James J. Hsieh

James J. Hsieh, MD, PhD


Department of Medicine

Oncology Division

Molecular Oncology

Medical Oncology

Clinical Interests

  • Kidney cancer

Research Interests

  • Kidney cancer metabolomics
  • Genomics, Epigenetics
  • Therapeutics, Precision Medicine
  • Translational kidney cancer research
  • Mouse tumor models, Mouse development
  • Drug development
  • Taspase1, Notch, MLL, Stem cells


  • 314-454-8681 (office)
  • 314-273-1688 (lab)
  • 314-362-7086 (fax)
  • Division of Oncology
    Campus Box 8069
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • 554 McDonnell Medical Sciences Building (office)


1983-1990 MD, Taipei Medical University, Taipei, Taiwan
1992-1996 PhD, Johns Hopkins University School of Medicine, Baltimore, MD
Post-doctoral Training
1996-1997 Postdoctoral Fellow, Johns Hopkins University School of Medicine, Baltimore, MD
1997-1999 Medicine Intern/Resident, Barnes Jewish Hospital, St. Louis, MO
1999-2000 Oncology Fellow, Barnes Jewish Hospital, St. Louis, MO
2000-2003 Oncology Fellow, Dana Farber Cancer Institute, Boston, MA
Academic Positions
2003-2004 Instructor, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
2004-2010 Assistant Professor, Washington University School of Medicine, St. Louis, MO
2010 Associate Professor, Washington University School of Medicine, St. Louis, MO
2010-2016 Associate Member, Memorial Sloan-Kettering Cancer Center, New York, NY
2011-2016 Associate Professor, Weill Medical College, Cornell University, New York, NY
2017-present Professor, Washington University School of Medicine, St. Louis, MO
Board Certification
2000-2010 American Board of Internal Medicine
2002-2022 American Board of Internal Medicine, Medical Oncology
Professional Memberships
1996-present Phi Beta Kappa
2000-present American Society of Clinical Oncology
2004-2013 American Society of Hematology
2009-present Society of Chinese Bioscientists in America
2009-present American Association for Cancer Research
2010-present American Society for Clinical Investigation
Honors & Awards
1990 Graduate summa cum laude (3/158), Taipei Medical University
1996 Nineteenth Annual Young Investigators' Award, The Johns Hopkins University School of Medicine
1996 Phi Beta Kappa
2000 Physician-Scientist Fellowship Award, HHMI
2003 Howard Temin Award, K01, NCI
2005 Edward Mallinckrodt Jr. Foundation Award
2006 Basic Research Scholar, American Society of Hematology
2009 Basic Research Scholar, American Cancer Society
2010 American Society for Clinical Investigation
2015 Member, Medical and Scientific Steering Committee, Kidney Cancer Association (KCA)
2008-2010 ACS IRG Review Committee, Washington University, St. Louis, MO
2011-2016 MSK Translational Kidney Cancer Research Program, Founder/Director
2011-present TCGA Kidney Cancer Genomics Working Group
2012-2013 MSK Cycle for Survival Review Committee
2012-2014 AACR Kure It Kidney Cancer Review Committee
2012 Clinical TCGA, Kidney Cancer, Founder
2012 Rare Kidney Cancer Association, Founder
2013-2015 AACR Clinical and Translational Research Grants Review Committee
2014-2015 DOD CDMRP, Kidney Cancer Review Committee Chair
2015 AUA Review Committee
2015-present KCA Steering Committee
2017-present ASCI Young Investigator Review Committee
2017-present NCI Clinical Proteome Tumor Analysis Consortium RCC
2017-present Renal Cancer Clinical Trial Consortium (RCCTC) Founder
2018 NCI P01 Review Committee
Editorial Boards
Journal of Kidney Cancer and VHL
Kidney Cancer
Cell Stress
Translational Cancer Research
2020-present Editor-in-Chief, Clinical Genitourinary Cancer, Elsevier